Page last updated: 2024-10-31

neostigmine and Prostatic Neoplasms

neostigmine has been researched along with Prostatic Neoplasms in 1 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Prostatic Neoplasms: Tumors or cancer of the PROSTATE.

Research Excerpts

ExcerptRelevanceReference
"Out of 83 patients with prostate cancer, 42 (51%) had Gleason score 6 (12 (28."1.37Metabolic syndrome is associated with high grade Gleason score when prostate cancer is diagnosed on biopsy. ( Cantiani, A; Carluccini, A; De Nunzio, C; Freedland, SJ; Miano, R; Trucchi, A; Tubaro, A, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Nunzio, C1
Freedland, SJ1
Miano, R1
Trucchi, A1
Cantiani, A1
Carluccini, A1
Tubaro, A1

Other Studies

1 other study available for neostigmine and Prostatic Neoplasms

ArticleYear
Metabolic syndrome is associated with high grade Gleason score when prostate cancer is diagnosed on biopsy.
    The Prostate, 2011, Oct-01, Volume: 71, Issue:14

    Topics: Aged; Aged, 80 and over; Biopsy; Blood Glucose; Blood Pressure; Body Mass Index; Cholesterol, HDL; D

2011